Femelife Fertility Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.49 M
as on 05-07-2024
- Revenue 2.11%
(FY 2023)
- Profit 12.17%
(FY 2023)
- Ebitda -5.07%
(FY 2023)
- Net Worth 6.84%
(FY 2023)
- Total Assets 6.13%
(FY 2023)
About Femelife Fertility Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.49 M.
Sujit Sahu and Nabaneeta Padhy serve as directors at the Company.
- CIN/LLPIN
U85110TN2012PTC085572
- Company No.
085572
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2012
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Femelife Fertility Foundation Private Limited offer?
Femelife Fertility Foundation Private Limited offers a wide range of products and services, including Medical Treatment Services, Infertility Treatment.
Who are the key members and board of directors at Femelife Fertility Foundation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujit Sahu  | Director | 24-Apr-2012 | Current |
| Nabaneeta Padhy | Director | 24-Apr-2012 | Current |
Financial Performance of Femelife Fertility Foundation.
Femelife Fertility Foundation Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.11% increase. The company also saw a substantial improvement in profitability, with a 12.17% increase in profit. The company's net worth moved up by a moderate rise of 6.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Femelife Fertility Foundation?
In 2023, Femelife Fertility Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cosmopolis Hospitals Private LimitedActive 11 years 25 daysSujit Sahu and Nabaneeta Padhy are mutual person
Wisedane Academy Private LimitedActive 8 years 3 monthsSujit Sahu and Nabaneeta Padhy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 18 Feb 2020 | ₹7.49 M | Open |
How Many Employees Work at Femelife Fertility Foundation?
Unlock and access historical data on people associated with Femelife Fertility Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Femelife Fertility Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Femelife Fertility Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
